Associated with a manufacturing site of >100 KL capacity for uninterrupted commercial supplies (The site is WHO-GMP approved for APIs and DMFs have been filed for advanced intermediates for regulated markets)
GMP documentation from cGMP plant for global markets
Impurity synthesis with high level of characterization
CRO/CDMO/CRAMS services
Building blocks for peptide and Oligonucleotide APIs
